Inappropriate shocks in the subcutaneous ICD: Incidence, predictors and management

1997, A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators, N. Engl. J. Med., 33, 1576

Moss, 2002, Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction, N. Engl. J. Med., 346, 877, 10.1056/NEJMoa013474

Lee, 2009, ICD lead proarrhythmia cured by lead extraction, Heart Rhythm., 6, 613, 10.1016/j.hrthm.2009.01.039

Kleemann, 2007, Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of >10years, Circulation, 115, 2474, 10.1161/CIRCULATIONAHA.106.663807

Bardy, 2010, An entirely subcutaneous implantable cardioverter-defibrillator, N. Engl. J. Med., 363, 36, 10.1056/NEJMoa0909545

Gold, 2012, Head-to-head comparison of arrhythmia discrimination performance of subcutaneous and transvenous ICD arrhythmia detection algorithms: the START study, J. Cardiovasc. Electrophysiol., 23, 359, 10.1111/j.1540-8167.2011.02199.x

Olde Nordkamp, 2012, The entirely subcutaneous implantable cardioverter-defibrillator: initial clinical experience in a large Dutch cohort, J. Am. Coll. Cardiol., 60, 1933, 10.1016/j.jacc.2012.06.053

Burke, 2015, Safety and efficacy of the totally subcutaneous implantable defibrillator: 2-year results from a pooled analysis of the IDE Study and EFFORTLESS Registry, J. Am. Coll. Cardiol., 65, 1605, 10.1016/j.jacc.2015.02.047

Tu, 2014, Subcutaneous implantable-defibrillator is better to be a “collaborator” rather than a “replacement”, Int. J. Cardiol., 177, 51, 10.1016/j.ijcard.2014.09.072

Gold, 2014, Use of a discrimination algorithm to reduce inappropriate shocks with a subcutaneous implantable cardioverter-defibrillator, Heart Rhythm., 11, 1352, 10.1016/j.hrthm.2014.04.012

Lambiase, 2014, Worldwide experience with a totally subcutaneous implantable defibrillator: early results from the EFFORTLESS S-ICD Registry, Eur. Heart J., 35, 1657, 10.1093/eurheartj/ehu112

Pedersen, 2012, Evaluation oF FactORs ImpacTing CLinical Outcome and Cost EffectiveneSS of the S-ICD: design and rationale of the EFFORTLESS S-ICD Registry, Pacing Clin. Electrophysiol., 35, 574, 10.1111/j.1540-8159.2012.03337.x

van Rees, 2011, Inappropriate implantable cardioverter-defibrillator shocks incidence, predictors, and impact on mortality, J. Am. Coll. Cardiol., 57, 556, 10.1016/j.jacc.2010.06.059

Daubert, 2008, Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact, J. Am. Coll. Cardiol., 51, 1357, 10.1016/j.jacc.2007.09.073

Tan, 2014, Impact of programming strategies aimed at reducing nonessential implantable cardioverter defibrillator therapies on mortality: a systematic review and meta-analysis, Circ. Arrhythm. Electrophysiol., 7, 164, 10.1161/CIRCEP.113.001217

Moss, 2012, Reduction in inappropriate therapy and mortality through ICD programming, N. Engl. J. Med., 367, 2275, 10.1056/NEJMoa1211107

Gasparini, 2013, Effect of long-detection interval vs standard-detection interval for implantable cardioverter-defibrillators on antitachycardia pacing and shock delivery: the ADVANCE III randomized clinical trial, JAMA, 309, 1903, 10.1001/jama.2013.4598

Weiss, 2013, Safety and efficacy of a totally subcutaneous implantable-cardioverter defibrillator, Circulation, 128, 944, 10.1161/CIRCULATIONAHA.113.003042

Gold, 2014, Use of a discrimination algorithm to reduce inappropriate shocks with a subcutaneous implantable cardioverter-defibrillator, Heart Rhythm., 11, 1352, 10.1016/j.hrthm.2014.04.012

Olde Nordkamp, 2014, Which patients are not suitable for a subcutaneous ICD: incidence and predictors of failed QRS-T-wave morphology screening, J. Cardiovasc. Electrophysiol., 25, 494, 10.1111/jce.12343

Kooiman, 2014, Inappropriate subcutaneous implantable cardioverter-defibrillator shocks due to T-wave oversensing can be prevented: implications for management, Heart Rhythm., 11, 426, 10.1016/j.hrthm.2013.12.007

Brisben, 2015, A new algorithm to reduce inappropriate therapy in the S-ICD system, J. Cardiovasc. Electrophysiol., 26, 417, 10.1111/jce.12612